Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene
- PMID: 10800077
- DOI: 10.1038/sj.cdd.4400675
Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene
Abstract
Oncogenic and anti-apoptotic Bcl-2 is expressed much less in estrogen receptor alpha (ERalpha) negative breast cancers, which show more malignant phenotypes, than ERalpha-positive, indicating that some other Bcl-2 family member(s) are involved in the apoptotic balance of the cancer cells. We first analyzed mRNA expression of pro-apoptotic Bak and Bax along with that of anti-apoptotic Bcl-2 and Bcl-xL, using breast cancer specimens of 27 patients. Bak mRNA was expressed much less in ERalpha negative breast cancers, along with reduced expression of Bcl-2. Immunostaining of sections of 108 patients confirmed the observation. Next, stable transformants of MCF-7 cells with sense Bak expression vector showed fewer colonies in soft agar compared with the parental cells, while stable introduction of antisense Bak vector enhanced colony formation at lower estradiol concentrations. The reduction of Bak may play important roles in malignant development of breast cancer to acquire estrogen independency, counteracting the reduced Bcl-2.
Similar articles
-
Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.Cancer Res. 1996 May 15;56(10):2422-7. Cancer Res. 1996. PMID: 8625322
-
In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.J Pathol. 1999 Mar;187(4):410-5. doi: 10.1002/(SICI)1096-9896(199903)187:4<410::AID-PATH266>3.0.CO;2-F. J Pathol. 1999. PMID: 10398099
-
Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.Anticancer Res. 2003 Jan-Feb;23(1B):565-8. Anticancer Res. 2003. PMID: 12680147
-
Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.Oncogene. 2016 Apr 14;35(15):1877-87. doi: 10.1038/onc.2015.287. Epub 2015 Aug 10. Oncogene. 2016. PMID: 26257067 Review.
-
Prognostic significance of apoptosis regulators in breast cancer.Endocr Relat Cancer. 1999 Mar;6(1):29-40. doi: 10.1677/erc.0.0060029. Endocr Relat Cancer. 1999. PMID: 10732784 Review.
Cited by
-
High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.PLoS One. 2015 Sep 25;10(9):e0138955. doi: 10.1371/journal.pone.0138955. eCollection 2015. PLoS One. 2015. PMID: 26406239 Free PMC article.
-
Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner.Mol Cell Biol. 2001 Jun;21(11):3684-91. doi: 10.1128/MCB.21.11.3684-3691.2001. Mol Cell Biol. 2001. PMID: 11340162 Free PMC article.
-
ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.J Biol Chem. 2008 Sep 5;283(36):25003-13. doi: 10.1074/jbc.M802511200. Epub 2008 Jul 3. J Biol Chem. 2008. PMID: 18599488 Free PMC article.
-
ERα activity depends on interaction and target site corecruitment with phosphorylated CREB1.Life Sci Alliance. 2018 Jun 7;1(3):e201800055. doi: 10.26508/lsa.201800055. eCollection 2018 Jun. Life Sci Alliance. 2018. PMID: 30456355 Free PMC article.
-
Nonredundant role of Bax and Bak in Bid-mediated apoptosis.Mol Cell Biol. 2003 Jul;23(13):4701-12. doi: 10.1128/MCB.23.13.4701-4712.2003. Mol Cell Biol. 2003. PMID: 12808108 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials